Index by Author

January 2018, Volume 25, Number 1
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abadi, Uri

  2. Abd Elmageed, Zakaria Y

  3. Amarasinghe, Kaushalya

  4. Ambrosio, Maria Rosaria

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  5. Ashur-Fabian, Osnat

B

  1. Bagheri, Nasser

  2. Balachander, Shiva

  3. Benn, Diana E

  4. Bironzo, Paolo

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

  5. Bondanelli, Marta

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  6. Boot, Arnoud

  7. Boulares, A Hamid

  8. Brown, Justin C

  9. Buttigliero, Consuelo

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

C

  1. Cameron, Daniel L

  2. Candiloro, Ida L M

  3. Chan, Franky L

  4. Clifton-Bligh, Roderick J

  5. Cohen, Keren

  6. Colao, Annamaria

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  7. Corver, Willem E

  8. Courneya, Kerry S

D

  1. Dai, Leheyi

  2. Damjanov, Nevena

  3. Davis, Paul J

  4. Demmers, Joris

  5. Di Maio, Massimo

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

  6. Dobrovic, Alexander

  7. Doi, Suhail A R

  8. Dwight, Trisha

E

  1. Ellis, Martin

F

  1. Faggiano, Antongiulio

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  2. Flynn, Aidan

  3. Friedlander, Paul

  4. Fujita, Kazutoshi

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

  5. Furuya-Kanamori, Luis

G

  1. Gill, Anthony J

  2. Glasziou, Paul

  3. Green, Erik A

H

  1. Hercbergs, Aleck

  2. Hicks, Rodney J

  3. Hogg, Annette

  4. Huang, Hong

K

  1. Kandil, Abdulrahman

  2. Kandil, Emad

  3. Kawashima, Atsunari

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

  4. Khan, Abdul Razzaq

  5. Ky, Bonnie

L

  1. Leone, Gianmarco

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

  2. Li, Jason

  3. Lupat, Richard

M

  1. Marotta, Vincenzo

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  2. Miyagawa, Yasushi

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

  3. Morreau, Hans

  4. Murad, Fadi

N

  1. Nagahara, Akira

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

  2. Ng, Chi-Fai

  3. Nonomura, Norio

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

O

  1. Onitilo, Adedayo A

  2. Oosting, Jan

P

  1. Papenfuss, Anthony T

  2. Pignataro, Daniele

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

Q

  1. Qian, Guanhua

R

  1. Rhim, Andrew D

  2. Rickels, Michael R

  3. Robinson, Bruce G

  4. Ruano, Dina

  5. Rustgi, Anil K

S

  1. Sahraeian, Shima

  2. Scagliotti, Giorgio V

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

  3. Schmitz, Kathryn H

  4. Sciammarella, Concetta

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  5. Sedrakyan, Art

  6. Sholl, Andrew B

  7. Sobti, Saboori

T

  1. Teoh, Jeremy Yuen-Chun

  2. Tothill, Richard W

  3. Troxel, Andrea B

  4. Tsumagari, Koji

  5. Tucci, Marcello

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

U

  1. Uemura, Motohide

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

  2. Ujike, Takeshi

    • A novel model to predict positive prostate biopsy based on serum androgen level Endocr Relat Cancer 25 (1) 59-67, doi:10.1530/ERC-17-0134 first published on 18 October 2017
      OPEN ACCESS ARTICLE

V

  1. Vignani, Francesca

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

W

  1. Wan, Biao

  2. Wang, Li

  3. Wang, Yuliang

  4. Wang, Zhu

  5. Wezel, Tom van

  6. Wong, Stephen Q

  7. Wu, Dinglan

Y

  1. Yu, Shan

  2. Yu, Tinghe

Z

  1. Zatelli, Maria Chiara

    • Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame Endocr Relat Cancer 25 (1) R11-R29, doi:10.1530/ERC-17-0269 first published on 24 October 2017

  2. Zemel, Babette S

  3. Zhang, Ying

  4. Zichi, Clizia

    • Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer Endocr Relat Cancer 25 (1) R1-R9, doi:10.1530/ERC-17-0355 first published on 28 September 2017

New Articles: issue in progress

  1. July 2018, 25 (7)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most